Loading...
The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective Immunity
BACKGROUND: The current vaccine against tuberculosis (TB), BCG, has failed to control TB worldwide and the protective efficacy is moreover limited to 10–15 years. A vaccine that could efficiently boost a BCG-induced immune response and thus prolong protective immunity would therefore have a signific...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3386939/ https://ncbi.nlm.nih.gov/pubmed/22768165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0039909 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|